ESTRO 2026
Stockholm, Sweden | 15–19 May 2026
This report brings together highlights from ESTRO 2026, presented under the theme "Innovating Radiation Oncology, Together." It compiles contributions from the Society's focus groups, tracks and committees, alongside this year's award-winning research, offering an overview of the scientific discussions and outcomes from the congress.
I. Reports by Focus Groups
- Breast
Highlights on breast cancer
By Lisa Ciaptacz
- CNS
ESTRO: A growing platform for neuro-radiation oncology
By Raphael Bodensohn
- Gastrointestinal
Lower GI
Lower GI in motion
By Letizia Deantonio
Upper GI
Radiation Oncology in upper GI Cancers
By Thomas Brunner, Francesco Cellini, Peter van Rossum, Tiuri Kroese, Eleni Gkika, Marcel Verheij, Eva Versteijne, Paul Rogowski, Siyer Roohani, Florence Huguet
- Gynaecological
Emerging Radiotherapy Strategies in Gynaecological Malignancies
By Bianca Santo and Donato Pezzulla
- Hyperthermia
Hyperthermia in modern radiation oncology: clinical evidence, biological diversity, technical innovation, and multi-centre harmonisation
By Anton Rink
- Lung
Highlights in Lung Cancer
By Valeria Dionisi and Kim Rosalie Kampen
- Oligometastatic disease
Prostate, gynae and lung
By Melek Tugce Yilmaz Aslan
Optimising oligometastatic disease management with circulating tumour DNA
By Oded Icht
Highlights of Studies on Oligometastatic Disease
By Nicolas Martz
- Positioning and Immobilisation
Positioning and Immobilisation Journey
By Ghizela Ana Maria Salagean, Siret Kivistik, Mirjam Mast and Prakash Umbarkar
- SBRT
Highlights on Renal Cell Carcinoma Sessions
By Harley Stephens
- Skin and soft tissue
Advances in Skin Cancer and Soft-tissue Sarcoma Treatment - Insights from ESTRO 2026
By Romaana Mir and Siyer Roohani
- Systemic therapy and RT
SFRT on the Rise
By Dora Correia and Verdiana Trappetti
- Urology
Urology highlights
By Thomas Zilli, Paul Sargos, Monica Buijs, Giulio Francolini and Simon Spohn
II. Track and Committees Reports
- Brachytherapy
Is There a Place for Interventional Radiotherapy (Brachytherapy) in Prostate Cancer?
By Hathal Haddad
- Physics
Direct Generation of VMAT Plans from Dose and Contours Using Deep Learning for Pancreatic Cancer
By Zixu Guan
Status and practice of proton therapy for pregnant patients in Europe
By Maite Romero-Expósito
Real or fake? A quad-modal digital patient engine brings virtual clinical trials a step closer in radiation oncology
By Muheng Li
Dose Surface Mapping of the Pharyngeal Mucosa Reveals Subregions Associated with Feeding Tube Dependency During Radiotherapy: Results from the UPGRADE-RT Multicentre Randomised Controlled Trial
By Sven Meijer
- RTT
Beyond Partnership: Advancing Patient Voice, Leadership, and Shared Decision-Making in Radiation Oncology
By Claire Poole
The Role of Clinical Audits in Driving Performance in Radiotherapy
By Maeve Kearney
Online Adaptive Radiotherapy and RTT educational programmes - Debate
By Emma-Jane White
An RTT's View of ESTRO 2026: Innovation, Debates, and Swedish Fika
By Sarah Fortin Jørgensen
- Radiobiology
Systemic responses to radiotherapy: from idea to implementation
By Heidi Lyng
Improving Re-Irradiation Outcomes: A Lively Debate at ESTRO
By Monica Mangoni
ESTRO meets MELODI: Immune consequences of radiation exposure
By Serge Candéias, Katalin Lumniczky and Anna Dubrovska
- Early Career
Bridging Worlds: Telemedicine for Global Cancer Care
By Federico Mastroleo and Laia Humbert-Vidan
- ROSQ (Radiation Oncology Safety and Quality)
The role of clinical audits in driving performance in radiotherapy
By Aileen Flavin
NB: The clinical track is covered in the previous section, within the various reports of the focus groups section.
III. Awards
Best Papers
- Brachytherapy
Can partial-breast irradiation be delivered in a single fraction? 10-year results of the SiFEBI phase II prospective trial
By Laura Haas
- Interdisciplinary
Bridging the Artificial Intelligence Readiness Gap: Quantifying Workforce Literacy in Radiation Oncology
By Ciaran Malone
- Physics
Advancing synthetic CT in radiotherapy: insights from the SynthRAD2025 Grand Challenge
By Matteo Maspero
Journal Awards
- CtRO Young Researcher Award
Long-term results of radiation therapy de-escalation in cT1-2N1 breast cancer after primary systemic treatment
By Fleur Mauritz
- PhiRO Young Researcher Award
A superconducting electron accelerator irradiation system with 1-30 MeV beam energy and widely tunable dose rates, for FLASH-RT biological and preclinical research
By Jianhan Sun
- TipsRO Young Researcher Award
Impact of breath-hold home training on spirometry-based DIBH eligibility in left-breast radiotherapy: Results from a single-arm prospective study
By Muhammad Fairuz Bin Jum'ee
Company Awards
- ESTRO-ELEKTA Brachytherapy Award
Very accelerated partial-breast irradiation: a step forward in breast cancer radiotherapy
By Jean-Michel Hannoun-Levi
- GEC-ESTRO Best Junior Presentation
Anal Canal Carcinoma: Which Patients Still Benefit From an Interstitial Brachytherapy Boost — And Is HDR the New Standard?
By Grégoire Laurent Delanghe
IV. Video interviews
In addition to the written reports above, a series of interviews was recorded on site in Stockholm, featuring abstract presenters and leading voices from across the congress. These recordings are available for viewing below.
Optimizing oligometastatic disease management with circulating tumour DNA: a correlative analysis from the phase II randomized EXTEND trial
Presenter: Alexander D Sherry, USA
> Watch the video
Final Results of the TROG 15.03 FASTRACK II Clinical Trial: Stereotactic Ablative Body Radiotherapy (SABR) for Primary Kidney Cancer
Presenter: Shankar Siva, Australia
> Watch the video
Geographic accessibility of proton therapy services in Europe
Presenter: Dominik Wawrzuta, Poland
Proton therapy for pregnant patients in Europe
Presenter: Maite Romero-Expósito, Sweden
> Watch the video
Impact of AI-Avatar Based Digital Patient Engagement on Treatment Understanding, Empowerment and Stress in a US Community Radiation Oncology Practice
Presenter: Adam Raben, USA
> Watch the video
Metastases-directed treatment in Patients with Oligometastatic Breast Cancer: Results from the OLIGOMA-trial ARO-2021-09
Presenter: David Krug, Germany
> Watch the video
HERMES: 2-year outcomes of a randomised phase II trial of 2-fraction and 5-fraction MRI-guided adaptive radiotherapy for prostate cancer
Presenter: Sian Cooper, UK
> Watch the video
HERMES: 2-year outcomes of a randomised phase II trial of 2-fraction and 5-fraction MRI-guided adaptive radiotherapy for prostate cancer
Presenter: Sian Cooper, UK
> Watch the video
Interview with the 2026 ESTRO Honorary Member Awardees
Laura Dawson, University of Toronto, Canada I David Palma, Western University, Canada
> Watch the video
Interview with Neha Vapiwala
President of ASTRO (American Society for Radiation Oncology)
University of Pennsylvania, Philadelphia, PA, USA
> Watch the video
Interview with Supriya Chopra
Research Committee Chair of FARO (Federation of Asian Organizations for Radiation Oncology)
Chair-elect Gynaecology GEC-ESTRO
Tata Memorial Centre, Mumbai, India
> Watch the video
Interview with Alina Strudza
Recipient of the Emmanuel van der Schueren Award
Medical University of Vienna, Austria
> Watch the video
Interview with Daniel Zips
Recipient of the Regaud Award
Charité, Berlin, Germany
> Watch the video
Interview with Cancer Patients Europe
Antonella Cardone, CEO Cancer Patients Europe
Merel Hennink, Secretary of Board Cancer Patients Europe
> Watch the video
Interview with Azadeh Abravan
Chair of the ESTRO Early Career Committee
University of Edinburgh, UK
> Watch the video
Interview with Luca Boldrini
Chair of the ESTRO Education Council
Fondazione Policlinico Universitario
“A. Gemelli” IRCCS of Rome, Italy
> Watch the video
Acknowledgements
We extend our sincere thanks to the authors, Focus Groups, and Committees whose contributions made this report possible. Their dedication to capturing and sharing the scientific highlights of ESTRO 2026 is greatly appreciated.
This report was compiled by the ESTRO Communications team. For corrections or additions, please contact chardon@estro.org.